stocksCORONA
CORONA

CORONA Remedies Ltd.

2,100.00+23.0 (+1.11%)
8 Sep, 12:00 AM

Annual Reports and Financial Documents

CORONA Remedies Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20252026
Annual ReportsFY 2026
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

CORONA Remedies Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Analyst / Investor Meet20 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation of participation in Analyst / Investor Conference
  2. Analyst / Investor Meet10 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation for Schedule of Analysts / Investor Conference
  3. Analyst / Investor Meet3 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    Audio Recording of Q1 FY27 Earnings Conference Call with Analysts / Investors
  4. Newspaper Publication1 Aug 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication of Unaudited Financial Results for the first quarter and three months ended June 30, 2026
  5. Press Release / Media Release31 Jul 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release on Financial Results for Q1FY27
  6. Outcome of Board Meeting31 Jul 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Outcome of Board Meeting
  7. Analyst / Investor Meet22 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Intimation for Schedule of Analysts / Investor Conference
  8. Board Meeting17 Jul 2026
    Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results On Standalone And Consolidated Basis For First Quarter And Three Months Ended June 30, 2026
    Corona Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
  9. AGM10 Jul 2026
    Shareholders Meeting / Postal Ballot- Scrutinizer''s Report
    Declaration of Voting Results and Scrutinizer''s Report for 22nd Annual General Meeting
  10. AGM9 Jul 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Outcome of 22nd Annual General Meeting
  11. General6 Jul 2026
    Compliances-Certificate Under Reg. 74(5) Of SEBI (DP) Regulations, 2018
    Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the first quarter ended June 30, 2026
  12. Press Release / Media Release30 Jun 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press Release for Commencement of Commercial Production
  13. General30 Jun 2026
    Commencement Of Commercial Production
    Intimation under Regulation 30 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015-Commencement of Commercial Production
  14. Closure of Trading Window29 Jun 2026
    Closure of Trading Window
    Intimation of Closure of Trading Window for dealing in securities of CORONA Remedies Limited in terms of SEBI (Prohibition of Insider Trading) Regulations, 2015
  15. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201119 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sepia Investments Ltd & Others
  16. Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201119 Jun 2026
    Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sepia Investments Ltd & Others
  17. Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201119 Jun 2026
    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual Fund
  18. Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201119 Jun 2026
    Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
    The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual Fund
  19. Newspaper Publication16 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication - Notice of 22nd Annual General Meeting , Intimation of Record Date and E-voting information
  20. General15 Jun 2026
    Communication To Shareholders
    Communication to Shareholders - Annual Report 2025-26

Frequently Asked Questions

Where can I download the annual report of CORONA Remedies Ltd.?
Annual reports of CORONA Remedies Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of CORONA Remedies Ltd.?
Quarterly earnings results and presentations of CORONA Remedies Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does CORONA Remedies Ltd. publish earnings call transcripts?
Earnings call transcripts of CORONA Remedies Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of CORONA Remedies Ltd.?
Investor presentations and annual day presentations of CORONA Remedies Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of CORONA Remedies Ltd.?
Corporate announcements and regulatory filings of CORONA Remedies Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of CORONA Remedies Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of CORONA Remedies Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of CORONA Remedies Ltd.?
The ISIN (International Securities Identification Number) of CORONA Remedies Ltd. is INE02ZQ01018. This is the unique identifier used across exchanges and depositories.
On which stock exchange is CORONA Remedies Ltd. listed?
CORONA Remedies Ltd. is listed on NSE and BSE. The NSE symbol is CORONA and the BSE code is -.
Where can I find the shareholding pattern of CORONA Remedies Ltd.?
The quarterly shareholding pattern of CORONA Remedies Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for CORONA Remedies Ltd. on Sharpely?
Share price data for CORONA Remedies Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.